Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Regulatory mechanisms linking HSF1 protein levels and HSF1 protein activity to the alternative splicing factor SF3B1

Award Number: R15CA227573
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 02/01/2019
PERIOD OF PERFORMANCE END DATE: 01/31/2023

Group Awards By:

View Award Description

Regulatory mechanisms linking HSF1 protein levels and HSF1 protein activity to the alternative splicing factor SF3B1 - Project summary A fundamental gap in understanding exists between clinical observations on the importance of HSF1 levels in cancer and a complete knowledge of the mechanisms that drive HSF1 regulation. Tragically, breast cancer patients expressing both high HSF1 levels and high HSF1 activity exhibit a precipitous decrease in metastasis- free survival by 5 years (<15%) compared to patients expressing either high levels or high activity of HSF1 (~60%), or patients where neither HSF1 levels nor activity is high (>75%). HSF1 is the master regulator of the heat shock response that functions to maintain cellular protein folding homeostasis. While the regulation of HSF1 protein activity during acute stress has been heavily studied, little is known about the mechanisms that regulate HSF1 protein levels, or how HSF1 protein activity is dysregulated in cancer cells. The HSF1 gene is rarely mutated in cancer genomes, indicating that the aberrant levels of HSF1 in cancer are not driven by a mutation in the gene itself and must lie in another factor. We have recently identified a new regulator, the alternative splicing factor SF3B1, which controls both HSF1 protein levels and HSF1 protein activity. Intriguingly, gain-of-function mutations in SF3B1 are enriched in several cancers and small molecule inhibitors of SF3B1 have potent antitumor activity. Our long-term goal is to uncover the regulatory mechanisms connecting SF3B1 and HSF1, probe their involvement in breast cancer and other cancers, and exploit this pathway for the development of anticancer therapeutics. The overall objective of this proposal is to define both the direct and the indirect regulatory mechanisms connecting SF3B1 and HSF1. Our central hypothesis, based on our recent publication and preliminary data, is that SF3B1 simultaneously affects the cellular levels of the HSF1 protein and disables the negative feedback loops known to regulate its activity via distinct mechanisms. Completion of our first specific aim will reveal the steps in HSF1 gene expression sensitive to SF3B1, identify the necessary sequence elements and uncover candidate genes that mediate these effects. Our second specific aim will define a new regulatory pathway where SF3B1 indirectly influences HSF1 activity via the alternative splicing of an intermediary factor. Our approach is innovative because other HSF1 regulators are not known to affect both HSF1 levels and HSF1 activity. This proposed research is significant because it will enable new insights into HSF1 regulation that may be important for its role in normal growth, stress responses, development, and aging. Additionally, this research will provide a foundation for future work evaluating the role of the interaction between SF3B1 and HSF1 in breast cancer. Finally, this proposal will serve to significantly enhance exposure of students to biomedical research at the Florida Institute of Technology and strengthen the research infrastructure of the university, making it a perfect fit for an R15 AREA grant.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $0 )
2024	2019	FLORIDA INSTITUTE OF TECHNOLOGY INC	150 W UNIVERSITY BLVD	MELBOURNE	FL	32901	BREVARD	USA	Cancer Biology Research	000	1	1/9/2024	NEW	$0
														Subtotal = $0

Issue Date FY: 2019 ( Subtotal = $430,320 )
2019	2019	FLORIDA INSTITUTE OF TECHNOLOGY, INC.	150 W UNIVERSITY BLVD OFC	MELBOURNE	FL	32901	BREVARD	USA	Cancer Biology Research	000	1	1/22/2019	NEW	$430,320
														Subtotal = $430,320

Grand Total All Awards = $430,320

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Regulatory mechanisms linking HSF1 protein levels and HSF1 protein activity to the alternative splicing factor SF3B1

Award Number: R15CA227573

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 02/01/2019

PERIOD OF PERFORMANCE END DATE: 01/31/2023

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer